SCHEMBL5674253

SCHEMBL5674253

CCOC(=O)CC1(c2ccccc2OC)C(=O)Nc2ccc(Cl)cc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.48
ADCY8 P40145 1/20 0.47
ALDH1A1 P00352 1/20 0.46
CBX7 O95931 2/20 0.45
CDYL Q9Y232 2/20 0.45
IDO1 P14902 2/20 0.45
KMT2A Q03164 1/20 0.44
APP P05067 1/20 0.43
PSEN1 P49768 1/20 0.43
PSEN2 P49810 1/20 0.43
APH1B Q8WW43 1/20 0.43
NCSTN Q92542 1/20 0.43
APH1A Q96BI3 1/20 0.43
PSENEN Q9NZ42 1/20 0.43
CDYL2 Q8N8U2 1/20 0.41
CDY1; CDY1B Q9Y6F8 1/20 0.41
SCN9A Q15858 1/20 0.39
KCNQ3 O43525 1/20 0.38
KCNQ2 O43526 1/20 0.38
KCNQ4 P56696 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5676014 0.92 BRD4 (0.48) BRD4ADCY8ALDH1A1CBX7CDYL
SCHEMBL5674413 0.91 CBX7 (0.46) BRD4ADCY8ALDH1A1CBX7CDYL
SCHEMBL5675856 0.89 BRD4 (0.46) BRD4ADCY8ALDH1A1CBX7CDYL
SCHEMBL5675743 0.88 ALDH1A1 (0.47) BRD4ADCY8ALDH1A1KMT2AAPP
SCHEMBL2492359 0.87 CBX7 (0.48) BRD4ADCY8CBX7CDYLIDO1
SCHEMBL5675808 0.87 ALDH1A1 (0.45) BRD4ADCY8ALDH1A1KMT2AAPP
SCHEMBL5674796 0.86 BRD4 (0.48) BRD4ADCY8ALDH1A1CBX7CDYL
SCHEMBL5674786 0.81 IDO1 (0.46) BRD4ADCY8ALDH1A1CBX7CDYL
SCHEMBL5675760 0.78 BRD4 (0.45) BRD4ADCY8ALDH1A1
SCHEMBL5677566 0.78 CBX7 (0.48) BRD4ADCY8CBX7CDYLIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7119086-B2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use SANOFI-AVENTIS (FR) 2006-10-10 US disclosed
US-20040180878-A1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use SANOFI-AVENTIS (FR) 2004-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040180878-A1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use AVPR2, AVPR1A, AVPR1B BRD4 2751/4885ADCY8 1986/4885ALDH1A1 3049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.